Article Information
History
- July 24, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Cardiovascular medicine department IV of Xinxiang Central Hospital, Xinxiang Henan 453000, China
- 2Guangdong Nephrotic Drug Engineering Technology Research Center, The R&D Center of Drug for Renal Diseases, Consun Pharmaceutical Group, Dongpeng Avenue, No.71, Guangzhou, Guangdong 510530, China
- ↵*Correspondence to Junzheng Yang (yangjunzheng606403{at}163.com), Guangdong Nephrotic, Drug Engineering Technology Research Center, The R&D Center of Drug for Renal Diseases, Consun Pharmaceutical Group, Dongpeng Avenue, No.71, Guangzhou, Guangdong 510530, China.